[Clinical study of a new drug: Imudon, in the treatment of diseases of the oral mucosa and periodontium].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000942:Antigens, Bacterial / Q000008:administration & dosage* / Q000009:adverse effects; D000946:Antigens, Fungal / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D004338:Drug Combinations; D005035:Ethylmercury Compounds / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D009061:Mouth Mucosa; D010510:Periodontal Diseases / Q000188:drug therapy*; D013849:Thimerosal / Q000008:administration & dosage* / Q000009:adverse effects
D000942:Antigens, Bacterial; D000946:Antigens, Fungal; D004338:Drug Combinations; D005035:Ethylmercury Compounds; D013849:Thimerosal
Etude clinique d'un nouveau médicament: Imudon, dans le traitement des affections de la muqueuse buccale et du parodonte